INVESTORS & MEDIA
News Release
Regeneron to Report First Quarter 2017 Financial and Operating Results and Host Conference Call and Webcast on May 4, 2017
Conference Call Information
To access this call, dial (888) 771-4371 (
About
Regeneron (NASDAQ: REGN) is a leading science-based biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions. Regeneron commercializes medicines for eye diseases, high LDL-cholesterol, atopic dermatitis and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including rheumatoid arthritis, asthma, pain, cancer and infectious diseases. For additional information about the company, please visit www.regeneron.com or follow @Regeneron on Twitter.
Contact Information: |
|
Investor Relations |
Corporate Communications |
|
|
914.847.5126 |
914.847.3422 |
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/regeneron-to-report-first-quarter-2017-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-4-2017-300439302.html
SOURCE
News Provided by Acquire Media